Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Oxaliplatin 197Bevacizumab 163Fluorouracil 155Capecitabine 137Gemcitabine 133Leucovorin 112pembrolizumab 100Cisplatin 94Drug Therapy 89Irinotecan 81Radiotherapy 73sintilimab 70durvalumab 65Paclitaxel 64130-nm albumin-bound paclitaxel 64Specimen Handling 62Cetuximab 61lenvatinib 60tislelizumab 58Nivolumab 56Magnetic Resonance Spectroscopy 55Folfox protocol 55Blood Specimen Collection 52atezolizumab 48Biopsy 46Surgical Procedures, Operative 40Immune Checkpoint Inhibitors 38Taxes 37Albumin-Bound Paclitaxel 37HMPL-013 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hyaluronic Acid × Gastrointestinal × Clear all
NCT06077981 2025-05-01

Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

Instituto do Cancer do Estado de São Paulo

Phase NA Recruiting
30 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡